In its 10th year, the Lancet Countdown’s findings are stark: real progress in clean energy, adaptation, and evidence is being ...
Sickle cell disease is the most common haemoglobinopathy, affecting more than 7 million people worldwide.1 Despite ...
The treatment landscape of EGFR-mutated non-small-cell lung cancer harbouring exon 19 deletion or L858R mutations has ...
Radionuclide theranostics is transforming oncology by enabling more personalised treatment based on tumour biology. The ...
Latvia has one of the world's highest rates of alcohol consumption but recent policy changes are starting to lessen direct harms to health. Ed Holt reports.
For 70 years, corticosteroids have been the default treatment for sarcoidosis.1 Although the field has repeatedly tried to ...
Cancer experts fear a rise in cancer cases in Russia if a draft 2027 budget proposing a sharp cut of more than 90% in federal cancer funding is pushed through parliament.
Africa’s digital health revolution, marked by a rapid increase in the number of technologies and providers of electronic health records, mobile health applications, disease surveillance platforms, and ...
We thank Jordan Bakhriansyah and colleagues for their thoughtful commentary on our manuscript from the ATLAS individual patient data meta-analysis.1 Although their conceptual arguments merit ...
It was a 2015 Editorial in The Lancet Oncology discussing cancer in the transgender community, that set Alison Berner (Queen ...
About two decades after the initial description of anti-NMDA receptor encephalitis, autoimmune encephalitis has expanded from being considered a neurological rarity to become one of the most rapidly ...
Over the past four decades, England's regional mortality inequalities have widened among working‑age adults, with more rapid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results